Performance and validation of R-CHA2DS2VASc score for thromboembolism in patients with hypertrophic cardiomyopathy

Elliott, 2004, Hypertrophic cardiomyopathy, The Lancet, 363, 1881, 10.1016/S0140-6736(04)16358-7 Maron, 2002, Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 39, 301, 10.1016/S0735-1097(01)01727-2 Higashikawa, 1997, Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation, Jpn Circ J, 61, 673, 10.1253/jcj.61.673 Haruki, 2016, Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation, Stroke, 47, 936, 10.1161/STROKEAHA.115.012130 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Guttmann, 2015, Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA), Eur J Heart Fail, 17, 837, 10.1002/ejhf.316 Barra, 2013, Stroke prediction with an adjusted R-CHA2DS2VASc score in a cohort of patients with a Myocardial Infarction, Thromb Res, 132, 293, 10.1016/j.thromres.2013.06.025 Elliott, 2014, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, 35, 2733, 10.1093/eurheartj/ehu284 Olivotto, 2001, Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy, Circulation, 104, 2517, 10.1161/hc4601.097997 Kubo, 2009, Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy, Circ J, 73, 1599, 10.1253/circj.CJ-09-0140 Guttmann, 2014, Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review, Heart, 100, 465, 10.1136/heartjnl-2013-304276 Masson, 2015, Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis, Nephrol Dial Transplant, 30, 1162, 10.1093/ndt/gfv009 Holzmann, 2012, Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population, Ann Med, 44, 607, 10.3109/07853890.2011.582136 Bos, 2007, Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study, Stroke, 38, 3127, 10.1161/STROKEAHA.107.489807 Bouchi, 2009, Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes?, Hypertens Res, 32, 381, 10.1038/hr.2009.30 Yokoyama, 2008, Japan Diabetes Clinical Data Management Study G. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16, Diabet Med, 25, 1426, 10.1111/j.1464-5491.2008.02592.x Zheng, 2012, The association between glomerular filtration rate and stroke in hypertensive patients in rural areas of China, J Hypertens, 30, 901, 10.1097/HJH.0b013e328352abc0 Fanikos, 2017, Renal Function Considerations for Stroke Prevention in Atrial Fibrillation, Am J Med, 130, 1015, 10.1016/j.amjmed.2017.04.015 Piccini, 2013, Circulation, 127, 224, 10.1161/CIRCULATIONAHA.112.107128 O'Brien, 2019, Incremental prognostic value of renal function for stroke prediction in atrial fibrillation, Int J Cardiol, 274, 152, 10.1016/j.ijcard.2018.07.113 Wannamethee, 1997, Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke, Stroke, 28, 557, 10.1161/01.STR.28.3.557 Arnan, 2015, Postoperative blood urea nitrogen is associated with stroke in cardiac surgical patients, Ann Thorac Surg, 99, 1314, 10.1016/j.athoracsur.2014.11.034 Filippatos, 2007, Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study, J Card Fail, 13, 360, 10.1016/j.cardfail.2007.02.005 Giamouzis, 2009, Incremental value of renal function in risk prediction with the Seattle Heart Failure Model, Am Heart J, 157, 299, 10.1016/j.ahj.2008.10.007 Klein, 2008, Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF), Circ Heart Fail, 1, 25, 10.1161/CIRCHEARTFAILURE.107.746933 Cauthen, 2008, Relation of blood urea nitrogen to long-term mortality in patients with heart failure, Am J Cardiol, 101, 1643, 10.1016/j.amjcard.2008.01.047 Guttmann, 2018, Atrial fibrillation and thromboembolism in hypertrophic cardiomyopathy - An underestimated risk, Int J Cardiol, 273, 187, 10.1016/j.ijcard.2018.09.058